The global nuclear medicine equipment market is poised for steady expansion, with revenues projected to grow from USD 2.6 billion in 2025 to USD 3.9 billion by 2035, reflecting a compound annual growth rate (CAGR) of 4.1% over the forecast period. This growth underscores the sector’s vital role in advancing diagnostic accuracy and therapeutic planning across oncology, cardiology, neurology, and other disease areas.
Key Market Highlights
- Market Value 2025 (E): USD 2.6 billion
- Forecast Value 2035 (F): USD 3.9 billion
- CAGR (2025–2035):1%
- Leading Product Segment 2025: SPECT (33.8% market share)
- Top Growth Regions: North America, Asia-Pacific, and Europe
- Key Industry Leaders: Siemens Healthineers AG, Philips Healthcare, GE Healthcare, Digirad Corporation, Mediso Medical Imaging Systems Ltd., and others
Click Here for More Information:- https://www.futuremarketinsights.com/reports/nuclear-medicine-equipment-market
Industry Growth Drivers
The demand for nuclear medicine equipment is accelerating due to:
- Rising incidence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders, requiring early and precise diagnostic imaging.
- Technological advancements including hybrid PET/CT, SPECT/CT, and AI-enabled imaging analytics that improve diagnostic confidence and efficiency.
- Increased government and private investment in healthcare infrastructure, particularly in molecular imaging and radiopharmaceutical research.
- Expanding access to reimbursement policies and heightened awareness of early disease detection.
Notably, the oncology application segment is projected to hold 38.4% of revenues in 2025, reflecting the central role of nuclear imaging in tumor localization, staging, and therapy planning.
Segmental Insights
- By Product: SPECT remains the dominant product segment, with 8% market share in 2025, owing to its affordability, shorter scan times, and widespread use in cardiac and brain imaging. Hybrid PET, however, is expected to grow fastest due to its superior imaging resolution and 3D capabilities.
- By Application: Oncology leads the market, supported by the global rise in cancer incidence and the adoption of nuclear imaging in clinical guidelines. Cardiology and neurology are also key growth areas.
- By End User: Hospitals are forecast to represent 6% of total revenues in 2025, driven by centralized infrastructure, higher patient volumes, and investments in advanced imaging systems.
Regional Outlook
- North America: The largest regional market, fueled by robust healthcare infrastructure, high cancer prevalence, and continued investment in advanced imaging. The U.S. leads in radiopharmaceutical consumption, while Canada is a major supplier of Tc-99m isotopes.
- Asia-Pacific: Expected to post the fastest CAGR, led by Japan, China, and India. Rising geriatric populations and increased focus on neurological and oncology diagnostics are fueling demand.
- Europe: Demonstrates steady growth with strong adoption in Germany, France, and the UK, where hybrid imaging systems and academic research centers are advancing nuclear medicine applications.
Competitive Landscape and Benchmarking
Market competition is intensifying as key players invest in product launches, strategic collaborations, and geographic expansions.
- Siemens Healthineers, Philips Healthcare, and GE Healthcare dominate global market share through broad portfolios of PET, SPECT, and hybrid imaging systems.
- Emerging players such as Mediso Medical Imaging and SurgicEye GmbH are innovating with niche imaging solutions and AI integration.
- Recent industry developments include Curium’s acquisition of IASON (Austria, June 2024) to expand its European radiopharmaceutical footprint and Lantheus’ FDA approval of PYLARIFY (May 2024), the first commercially available PSMA PET imaging agent for prostate cancer.
Competitor benchmarking shows that industry leaders are increasingly focused on hybrid imaging, AI-driven diagnostics, and theranostic applications, aligning with broader healthcare digitalization trends.
Opportunities and Challenges
Opportunities:
- Hospitals remain the largest growth opportunity, supported by global healthcare spending increases and the shift toward early disease detection.
- Advances in digital SPECT and PET technologies, along with new radiotracer development, are expected to further expand clinical adoption.
- Emerging markets in Asia-Pacific present untapped potential, with China and India forecast to grow at 5% and 5.1% CAGR, respectively.
Challenges:
- High equipment costs and limited reimbursement in developing countries hinder adoption.
- Short half-life of radiopharmaceuticals requires localized production and logistics, adding operational complexity.
- Limited training in molecular imaging among clinicians continues to slow widespread adoption in certain regions.
Get Sample Report: – https://www.futuremarketinsights.com/reports/sample/rep-gb-14937
Industry Outlook
The nuclear medicine equipment market is well-positioned for sustained growth through 2035, supported by clinical innovation, demographic shifts, and strategic investments. As cancer and cardiovascular disease rates climb globally, the adoption of advanced imaging technologies is no longer optional but essential.
Industry experts forecast a strong pipeline of AI-enabled imaging platforms, theranostic solutions, and next-generation hybrid modalities that will reshape diagnostic workflows. Companies that prioritize technological integration, cost efficiency, and regional accessibility are expected to strengthen their market position significantly over the next decade.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
